Oral administration of the small molecule cathepsin S inhibitor LY3000328 accelerates disease onset and impairs glucose tolerance in non-obese diabetic miceT. Floyel, C. Frorup,M. Haupt-Jorgensen,L. J. Holm,K. Pedersen,M. O. Monsted,K. Buschard, J. Storling,F. PociotDIABETOLOGIA（2022）引用 0|浏览11暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
